Iron Sucrose Fixed Dose – A ‘Sprint‘ Therapy  For The Treatment Of Iron Deficiency Anemia  In Obstetric And Gynaec Patients

Dr. Kishorkumar H; Dr. Neelesh R; Dr. Sameer D

Volume : I, Issue : II, November - 2011

Iron Sucrose Fixed Dose – A ‘Sprint‘ Therapy For The Treatment Of Iron Deficiency Anemia In Obstetric And Gynaec Patients

Dr. Kishorkumar H, Dr. Neelesh R, Dr. Sameer D

Abstract :

Objectives: To study the efficacy and safety of fixed dose intravenous iron sucrose therapy in the treatment of iron deficiency anaemia in obstetric and gynaecological Patients. Method: Well compensated anemic patients with Hb between 5 9 gm% were included in the study. Patients were thoroughly investigated for hematological parameters. Each patient has received a fixed dose of 600 mg iron sucrose IV divided in three such doses every alternate day, followed by oral iron therapy to replenish the iron stores. Results: Average rise in Hb in moderate anemia group is 1.85, 2.60 & 3.40 gm% after 7, 14 & 28 days respectively after infusion. In severe anemia group Hb rise observed is 2.50, 3.73 & 4.70 gm% after 7, 14& 28 days respectively. Significant improvement in iron stores is also observed at the end of 28 days. Paired t test and Z test was used to test the significance of rise . Conclusion: Fixed dose iron sucrose and subsequent oral iron therapy is very useful for raising Hb rapidly and safely in patients with moderate and sever iron deficiency anemia.